Get the Stockscreener App
1.145
0.44%
0.005
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Operating Expenses
|
14.40%
4.3779
|
5.1146 | 3.115 | 3.4452 | 2.903 |
| Income/Loss From Continuing Operations Before Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Income/Loss From Continuing Operations After Tax |
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
|
Net Income/Loss
|
14.40%
-4.3779
|
-5.1146 | -3.115 | -3.4452 | -2.903 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Diluted Average Shares |
3,872%
15.47
|
0.3896 | 13.01 | 12.19 | 11.64 |
| Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.24 | -0.28 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):